Scientific work

Prof. Dr. Doğan Uncu

218 publications. The source of the information is stated next to each publication.

Back to profile

  1. Prognostic Significance of HER2 Positivity in Endometrium Cancer

    Oncology Research and Treatment, 2024

    DOI 10.1159/000542900 PMID 39616989 2 citations (OpenAlex) Source: OpenAlex

  2. Clinical features and prognostic factors in thymoma and thymic carcinoma

    Indian Journal of Thoracic and Cardiovascular Surgery, 2024

    DOI 10.1007/s12055-024-01741-6 PMID 39416339 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  3. Cabozantinib-induced heart failure

    Journal of Oncology Pharmacy Practice, 2024

    DOI 10.1177/10781552231203703 PMID 37817663 2 citations (Europe PMC) Source: ORCID

  4. Comparison of Different Machine Learning Models for Predicting Long-Term Overall Survival in Non-metastatic Colorectal Cancers

    Cureus, 2024

    DOI 10.7759/cureus.75713 PMID 39811215 14 citations (OpenAlex) Open-access full textSource: OpenAlex

  5. A rare EGFR exon 19 insertion mutation in metastatic lung adenocarcinoma: a favorable response to afatinib

    Anti-Cancer Drugs, 2024

    DOI 10.1097/cad.0000000000001671 PMID 39749551 Source: OpenAlex

  6. Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving Chemoimmunotherapy

    Expert Opinion on Pharmacotherapy, 2024

    DOI 10.1080/14656566.2024.2391007 PMID 39115275 4 citations (Europe PMC) Source: ORCID

  7. Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study

    Clinical and Translational Oncology, 2024

    DOI 10.1007/s12094-024-03410-x PMID 38451412 Source: ORCID

  8. 46P The frequency of driver mutations in non-small cell cancer patients: Analysis of the 5064 patients in the Turkish nation-wide, observational, registurkLung study

    ESMO Open, 2024

    DOI 10.1016/j.esmoop.2024.102625 Open-access full textSource: OpenAlex

  9. Primary colon lymphomas: An analysis of our experience over the last 18 years

    Medicine, 2024

    DOI 10.1097/md.0000000000038013 PMID 38728507 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. Clinicopathological features and treatment outcomes of urothelial carcinoma variant histologies and non-urothelial bladder cancers

    International Urology and Nephrology, 2024

    DOI 10.1007/s11255-024-04341-w PMID 39729262 5 citations (OpenAlex) Source: OpenAlex

  11. Is fibroblast growth factor 11 (FGF11) a predictive marker for breast cancer?

    Medicine, 2024

    DOI 10.1097/md.0000000000037656 PMID 38552037 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  12. How illness perception congruence between patients with cancer and caregivers affects their anxiety and depression levels

    Journal of Psychosocial Oncology Research and Practice, 2024

    DOI 10.1097/or9.0000000000000145 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  13. Sensitivity of frozen section analysis in patients with ovarian adult granulosa cell tumor, a multi-center study

    Archives of Gynecology and Obstetrics, 2024

    DOI 10.1007/s00404-024-07710-z PMID 39214901 1 citation (OpenAlex) Source: OpenAlex

  14. Management and prognosis of patients with cancer of unknown primary: 20 years of experience

    Turkish journal of medical sciences, 2023

    DOI 10.55730/1300-0144.5741 PMID 38813492 2 citations (Europe PMC) Open-access full textSource: Europe PMC

  15. Neoadjuvant Chemotherapy Followed by Cytoreductive Surgery and HIPEC Improves Survival in Peritoneal Metastatic Gastric Cancer

    Oncology, 2023

    DOI 10.1159/000528609 PMID 36809752 11 citations (OpenAlex) Source: OpenAlex

  16. Evaluation of clinical and prognostic factors for primary gastric diffuse large B-cell lymphoma: Single-center experience

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_2111_21 PMID 37470610 6 citations (OpenAlex) Open-access full textSource: OpenAlex

  17. Is adjuvant chemotherapy necessary for 2014 FIGO stage IC adult granulosa cell tumor?: Multicentric Turkish study

    Asia-Pacific Journal of Clinical Oncology, 2023

    DOI 10.1111/ajco.13942 PMID 37096294 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  18. A multicentre, multinational study of clinical characteristics and prognosis of hepatocellular carcinoma

    Eastern Mediterranean Health Journal, 2023

    DOI 10.26719/emhj.23.087 PMID 37551758 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  19. Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer

    African Journal of Urology, 2023

    DOI 10.1186/s12301-023-00398-8 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  20. The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer

    American Journal of Clinical Oncology, 2023

    DOI 10.1097/coc.0000000000001044 PMID 37700432 Source: OpenAlex

  21. #356 Sensitivity of frozen section analysis in patients with ovarian adult granulosa cell tumor, a multi-center study

    International Journal of Gynecological Cancer, 2023

    DOI 10.1136/ijgc-2023-esgo.564 Open-access full textSource: OpenAlex

  22. Is the watch‐and‐wait strategy suitable for every patient who has achieved a complete clinical response with neoadjuvant treatment in locally advanced rectum cancer?

    Journal of Surgical Oncology, 2023

    DOI 10.1002/jso.27537 PMID 38031877 Open-access full textSource: OpenAlex

  23. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma

    Bosnian Journal of Basic Medical Sciences, 2022

    DOI 10.17305/bjbms.2021.7069 PMID 35460397 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  24. The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients

    Pancreas, 2022

    DOI 10.1097/mpa.0000000000002167 PMID 37078939 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  25. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer

    Journal of Cancer Research and Therapeutics, 2022

    DOI 10.4103/jcrt.jcrt_1104_21 PMID 36510987 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  26. Clinicopathologİcal Features and Survival Outcomes of 70 Tongue Squamous Cell Carcinoma Patients

    Acta Oncologica Turcica, 2022

    DOI 10.5505/aot.2022.59002 Open-access full textSource: OpenAlex

  27. 120P Efficacy of postoperative radiotherapy (PORT) in stage IIIA-N2 non-small cell lung cancer: Meta-analysis of randomized controlled studies

    Annals of Oncology, 2022

    DOI 10.1016/j.annonc.2022.02.147 Open-access full textSource: OpenAlex

  28. The prognostic value of Sprouty2 protein in nonsmall cell lung cancer.

    Journal of Clinical Oncology, 2022

    DOI 10.1200/jco.2022.40.16_suppl.e20524 Source: OpenAlex

  29. Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00594-1 PMID 33538958 4 citations (Europe PMC) Source: OpenAlex

  30. Thirty-day mortality rates after immunotherapy initiation

    Immunotherapy, 2021

    DOI 10.2217/imt-2021-0082 PMID 34676791 2 citations (Europe PMC) Source: Europe PMC

  31. Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy

    Future oncology (London, England), 2021

    DOI 10.2217/fon-2021-0597 PMID 34342517 28 citations (Europe PMC) Open-access full textSource: Europe PMC

  32. The effect of chemotherapy on olfactory function and mucociliary clearance

    Supportive Care in Cancer, 2021

    DOI 10.1007/s00520-020-05639-y PMID 32749656 6 citations (Europe PMC) Source: ORCID

  33. Baseline 18F-FDG PET textural features as predictors of response to chemotherapy in diffuse large B-cell lymphoma

    Nuclear Medicine Communications, 2021

    DOI 10.1097/mnm.0000000000001447 PMID 34075009 20 citations (Europe PMC) Source: ORCID

  34. A Comparison of Osseous and Extraosseous Ewing Sarcoma

    Journal of College of Physicians And Surgeons Pakistan, 2021

    DOI 10.29271/jcpsp.2021.01.27 PMID 33546529 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  35. An Overview of Seminomatous and Non-Seminomatous Germ Cell Testicular Tumors: A Single-center Experience

    Bulletin of Urooncology, 2021

    DOI 10.4274/uob.galenos.2021.2021.3.1 Open-access full textSource: OpenAlex

  36. Does Prognostic Nutritional Index Predict Survival in Operated Papilla Vateri Tumors? A Single-centre Experience

    Journal of College of Physicians and Surgeons Pakistan, 2021

    DOI 10.29271/jcpsp.2021.12.1428 PMID 34794282 1 citation (Europe PMC) Open-access full textSource: ORCID

  37. The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study

    International Journal of Colorectal Disease, 2021

    DOI 10.1007/s00384-021-03888-9 PMID 33586012 28 citations (OpenAlex) Open-access full textSource: OpenAlex

  38. 976P The 30-day mortality rate after first cycle of immunotherapy

    Annals of Oncology, 2021

    DOI 10.1016/j.annonc.2021.08.1360 Open-access full textSource: OpenAlex

  39. The Relationship Between Plexin C1 Overexpression and Survival in Hepatocellular Carcinoma: a Turkish Oncology Group (TOG) Study

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00602-4 PMID 33656690 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  40. The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer

    Cureus, 2021

    DOI 10.7759/cureus.14882 PMID 34104608 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  41. Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data.

    PubMed, 2021

    PMID 34564997 4 citations (OpenAlex) Source: OpenAlex

  42. Is the nuclear factor kappa-b (NF-κB) pathway and inflammatory status associated with colorectal cancer?

    Saudi Journal of Gastroenterology, 2021

    DOI 10.4103/sjg.sjg_44_21 PMID 34380870 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  43. 570P Retrospective analysis of PDL-1, LAG3, TIM3, OX40L and MSI status in gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

    Annals of Oncology, 2021

    DOI 10.1016/j.annonc.2021.08.705 Open-access full textSource: OpenAlex

  44. 1226P Efficacy and safety of Anti-EGFR TKIs combined with bevacizumab or ramucirumab in the first-line treatment of non-small cell lung cancer: Meta-analysis of randomized controlled trials

    Annals of Oncology, 2021

    DOI 10.1016/j.annonc.2021.08.1831 Open-access full textSource: OpenAlex

  45. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer

    Tumori Journal, 2020

    DOI 10.1177/0300891620969823 PMID 33167790 4 citations (Europe PMC) Source: OpenAlex

  46. PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY)

    AYBU AVESIS, 2020

    Source: OpenAlex

  47. Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study

    Journal of Oncological Sciences, 2020

    DOI 10.37047/jos.2020-75080 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  48. The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer

    Asia-Pacific journal of clinical oncology, 2020

    DOI 10.1111/ajco.13328 PMID 32301263 16 citations (Europe PMC) Source: Europe PMC

  49. The Negative RT-PCR Test is Enough to Rule Out Covıd-19 in Cancer Patients or Not? Covıd-19 or Not?

    Journal of Biomedical Research & Environmental Sciences, 2020

    DOI 10.37871/jbres1141 Source: OpenAlex

  50. Clinical features and prognostic factors in small bowel tumors: A retrospective evaluation of eighty cases

    Annals of Medical Research, 2020

    DOI 10.5455/annalsmedres.2019.09.553 2 citations (OpenAlex) Open-access full textSource: OpenAlex